We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$124B
AUM Growth
+$20B
Cap. Flow
+$16.7B
Cap. Flow %
13.46%
Top 10 Hldgs %
20.91%
Holding
8,008
New
295
Increased
4,222
Reduced
2,579
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 6.83%
2 Financials 5.79%
3 Healthcare 5.06%
4 Consumer Discretionary 4.03%
5 Industrials 3.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRYS icon
5776
Krystal Biotech
KRYS
$10.8B
$99K ﹤0.01%
2,455
-19,659
-89% -$643K
MFG icon
5777
Mizuho Financial
MFG
$126B
$99K ﹤0.01%
34,787
-2,967
-8% -$8.8K
WHG icon
5778
Westwood Holdings Group
WHG
$182M
$99K ﹤0.01%
2,823
+317
+13% +$10.2K
XXII
5779
CALL
22nd Century Group
XXII
$1.34M
0
SYRS
5780
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$99K ﹤0.01%
1,069
+332
+45% +$23.1K
ASXC
5781
DELISTED
Asensus Surgical, Inc.
ASXC
$99K ﹤0.01%
5,573
+2,832
+103% +$62K
GNMK
5782
DELISTED
GenMark Diagnostics, Inc
GNMK
$99K ﹤0.01%
15,203
+1,208
+9% +$8.51K
QEP
5783
PUT
DELISTED
QEP RESOURCES, INC.
QEP
$99K ﹤0.01%
13,700
-1,500
-10% -$10.9K
OAK
5784
CALL
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$99K ﹤0.01%
2,000
-5,000
-71% -$248K
CSTE icon
5785
Caesarstone
CSTE
$71.6M
$98K ﹤0.01%
6,543
+88
+1% +$1.32K
PDT
5786
John Hancock Premium Dividend Fund
PDT
$636M
$98K ﹤0.01%
5,752
+1,840
+47% +$30.8K
TUSK icon
5787
Mammoth Energy Services
TUSK
$125M
$98K ﹤0.01%
14,355
-22,557
-61% -$287K
TXMD icon
5788
TherapeuticsMD
TXMD
$23.5M
$98K ﹤0.01%
748
-79
-10% -$14.2K
SRNE
5789
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$98K ﹤0.01%
36,672
+1,202
+3% +$4.33K
MTT
5790
DELISTED
Western Asset Municipal Defined Opportunity Trust Inc.
MTT
$98K ﹤0.01%
4,500
WLH
5791
DELISTED
WILLIAM LYON HOMES
WLH
$98K ﹤0.01%
5,384
-2,282
-30% -$41.1K
CACC icon
5792
CALL
Credit Acceptance
CACC
$5.81B
$97K ﹤0.01%
200
-1,100
-85% -$523K
EMHY icon
5793
iShares JPMorgan EM High Yield Bond ETF
EMHY
$619M
$97K ﹤0.01%
2,037
IRWD icon
5794
PUT
Ironwood Pharmaceuticals
IRWD
$614M
$97K ﹤0.01%
8,900
-2,562
-22% -$28.7K
LAKE icon
5795
Lakeland Industries
LAKE
$109M
$97K ﹤0.01%
8,630
MAN icon
5796
PUT
ManpowerGroup
MAN
$2.41B
$97K ﹤0.01%
1,000
+900
+900% +$82K
NEA icon
5797
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.37B
$97K ﹤0.01%
7,000
+5,000
+250% +$67.2K
NVEC icon
5798
NVE Corp
NVEC
$555M
$97K ﹤0.01%
1,396
+164
+13% +$13.7K
OIA icon
5799
Invesco Municipal Income Opportunities Trust
OIA
$293M
$97K ﹤0.01%
12,700
+10,200
+408% +$77.6K
PFO
5800
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$119M
$97K ﹤0.01%
8,304

Similar funds

Citigroup's Q2 2019 Portfolio in Review

As of Q2 2019, Citigroup held 8,008 positions worth $124B, up 19% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup deployed $16.7B of net new capital in Q2 2019, opening 295 new positions and adding to 4,222 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.12B trimmed.

  • Citigroup's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
  • Citigroup added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $2.43B increase.
  • Citigroup's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.12B.
  • Citigroup fully exited Integrated Device Technology I in Q2 2019, selling an estimated $126M.
  • Citigroup's ten largest holdings make up 21% of its $124B portfolio in Q2 2019.
  • Citigroup opened 295 new positions and closed 217 in Q2 2019.
  • Citigroup's portfolio value rose 19% quarter-over-quarter to $124B.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.